Patents by Inventor Chandra S. Arvizu

Chandra S. Arvizu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030211093
    Abstract: The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associatedd withd abberant expression of PKIN.
    Type: Application
    Filed: January 15, 2003
    Publication date: November 13, 2003
    Inventors: Henry Yue, Farrah A Khan, Rajagopal Gururajan, April J A Hafalia, Narinder K Chawla, Chandra S Arvizu, Jayalaxmi Ramkumar, Ameena R Gandhi, Jennifer L Policky, Mariah R Baughn, Catherine M Tribouley, Michael B Thornton, Olga Bandman, Danniel B Nguyen, Yan Lu, Neil Burford, Preeti G Lal, Li Ding, Monique G Yao, Vicki S Elliott, Shirley A Recipon, Liam Kearney, Dyung Aina M Lu, Sara R Greenwald, Y Tom Tang, Yuming Xu, Roderick T Walsh, Kimberly J Gietzen, Junming Yang, Jennifer L Jackson
  • Publication number: 20030211515
    Abstract: Polypeptides and polynucleotides of the genes set forth in Table 1 and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing polypeptides and polynucleotides of the genes set forth in Table 1 in diagnostic assays.
    Type: Application
    Filed: December 19, 2002
    Publication date: November 13, 2003
    Inventors: Amy K Lasek, Henry Yue, Chandra S Arvizu
  • Publication number: 20030207299
    Abstract: The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
    Type: Application
    Filed: November 1, 2002
    Publication date: November 6, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Danniel B. Nguyen, Narinder K. Chawla, April J. A. Hafalia, Monique G. Yao, Ameena R. Gandhi, Rajagopal Gururajan, Li Ding, Chandra S. Arvizu, Henry Yue, Mariah R. Baughn, Catherine M. Tribouley, Michael B. Thornton, Vicki S. Elliott, Yan. Lu, Craig H. Ison, Janice K. Au-Young, Y. Tom Tang, Yalda Azimzai, John D. Burrill, Gregory A. Marcus, Kurt A. Zingler, Dyung Aina M. Lu, Preeti G. Lal, Jayalaxmi Ramkumar, Bridget A. Warren, Liam Kearney, Jennifer L. Policky, Kavitha Thangavelu, Neil Burford
  • Publication number: 20030198975
    Abstract: The invention provides human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
    Type: Application
    Filed: October 31, 2002
    Publication date: October 23, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Yalda Azimzai, Janice Au-Young, Sajeev Batra, Mariah R. Baughn, Shanya D. Becha, Mark L. Borowsky, Neil Burford, Li Ding, Vicki S. Elliott, Brooke M. Emerling, Ameena R. Gandhi, Kimberly J. Gietzen, Jennifer A. Griffin, April J. A. Hafalia, Cynthia D. Honchell, Preeti G. Lal, Soo Yeun Lee, Dyung Aina M. Lu, Chandra S. Arvizu, Jayalaxmi Ramkumar, Roopa M. Reddy, Madhusudan S. Sanjanwala, Y. Tom Tang, Narinder K. Chawla, Yu-Mei E. Wang, Bridget A. Warren, Yuming Xu, Junming Yang, Monique G. Yao, Henry Yue, Yeganeh Zebarjadian
  • Publication number: 20030175754
    Abstract: The invention provides RVP variant, its encoding cDNAs, and antibodies that specifically bind the protein. The invention also provides for the use of these compositions in the diagnosis, prognosis, treatment and evaluation of progression and treatment of cell proliferative disorders.
    Type: Application
    Filed: November 5, 2002
    Publication date: September 18, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Lynn E. Murry, Jennifer L. Jackson, Y. Tom Tang, Chandra S. Arvizu
  • Publication number: 20030165933
    Abstract: The invention provides human apoptosis regulators (APRG) and polynucleotides which identify and encode APRG. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of APRG.
    Type: Application
    Filed: April 7, 2003
    Publication date: September 4, 2003
    Inventors: Y. Tom Tang, Yalda Azimzai, Henry Yue, Neil Burford, Li Ding, Vicki S. Elliott, Chandra S. Arvizu, Mariah R. Baughn
  • Publication number: 20030143588
    Abstract: The invention provides human phosphodiesterases (HPDE) and polynucleotides which identify and encode HPDE. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HPDE.
    Type: Application
    Filed: October 18, 2002
    Publication date: July 31, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Michael B. Thornton, Li Ding, Chandra S. Arvizu, Monique G. Yao, Catherine M. Tribouley, Preeti G. Lal, April J. A. Hafalia, Mariah R. Baughn, Jayalaxmi Ramkumar, Yan Lu, Narinder K. Chawla
  • Publication number: 20030143589
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: October 18, 2002
    Publication date: July 31, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Mariah R. Baughn, Christopher M. Bruns, Debopriya Das, Li Ding, Vicki S. Elliott, Ameena R. Gandhi, April J.A. Hafalia, Liam Kearney, Farrah A. Khan, Preeti G. Lal, Ernestine A. Lee, Dyung Aina M. Lu, Yan Lu, Danniel B. Nguyen, Chandra S. Arvizu, Jayalaxmi Ramkumar, Huijun Z. Ring, Madhusudan M. Sanjanwala, Y. Tom Tang, Kavitha Thangavelu, Michael B. Thornton, Catherine M. Tribouley, Narinder K. Chawla, Yuming Xu, Junming Yang, Monique G. Yao, Henry Yue
  • Publication number: 20030138818
    Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
    Type: Application
    Filed: October 21, 2002
    Publication date: July 24, 2003
    Inventors: Chandra S. Arvizu, Dyung Aina M. Lu, Michael B. Thornton, Yan Lu, Catherine M. Tribouley, Richard C. Graul, Farrah A. Khan, Ameena R. Gandhi, Narinder K. Chawla, Danniel B. Nguyen, Henry Yue, April J.A. Hafalia, Vicki S. Elliott, Preeti G. Lal, Roopa M. Reddy, Deborah A. Kallick, Y. Tom Tang, Janice K. Au-Young
  • Publication number: 20030113317
    Abstract: The invention provides a T cell death-associated protein, its encoding cDNA, and an antibody that specifically binds the protein. It also provides for the use of the cDNAs, protein and antibodies thereto to diagnose, stage, treat or monitor the progression or treatment of cancer, particularly breast adenocarcinoma.
    Type: Application
    Filed: October 23, 2002
    Publication date: June 19, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Henry Yue, Chandra S. Arvizu, Neil C. Corley, Karl J. Guegler
  • Publication number: 20030068787
    Abstract: The invention provides a human cyclophilin-type peptidyl-prolyl cis/trans isomerase (CPCI), a cDNA that encodes CPCI and an antibody that specifically binds CPCI. The invention also provides methods to diagnose, to stage, to treat, or to monitor the treatment of disorders associated with expression of CPCI.
    Type: Application
    Filed: June 20, 2002
    Publication date: April 10, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Jennifer L. Jackson, Neil C. Corley, Karl J. Guegler, Chandra S. Arvizu